An inexpensive, readily available oral anti-inflammatory drug can reduce the risk of hospitalisation and death for some patients with Covid-19, according to a study.Colchicine, which is currently prescribed to treat gout, familial Mediterranean .
A drug some researchers claimed to be incredibly promising in treating COVID-19 is, according to their more in-depth research, potentially promising, with the final results much more lukewarm than they were first described to be.
Results of the COLCORONA study published in The Lancet Respiratory Medicine | Comunicados | Edición USA efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.
Results of the COLCORONA study published in The Lancet Respiratory Medicine - News Makers newsmakers.pk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsmakers.pk Daily Mail and Mail on Sunday newspapers.